We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




AD Biomarkers in Ocular Fluid Indicate Dementia Risk

By LabMedica International staff writers
Posted on 25 Mar 2019
Measuring levels of amyloid-beta and tau proteins in the eye's vitreous humor has been suggested as means to detect dementia at an early stage in individuals at risk for Alzheimer's disease (AD).

Investigators at the Boston Medical Center (MA, USA) determined levels of amyloid-beta (Abeta) and tau protein in human vitreous humor and evaluated the clinical predictive role of these proteins as early diagnostic markers of AD.

For this study, vitreous humor samples from 80 eyes were measured quantitatively for Abeta42, pTau, and tTau. More...
Linear regression was used to test associations between AD biomarker levels, Mini-Mental State Exam (a baseline cognitive test), and serum apolipoprotein E (APOE) allele status, with adjustment for age, sex, and education level of patients.

Results revealed that patients with poor cognitive function had significantly lower vitreous humor levels of the AD-related biomarkers Abeta40, Abeta42, and tTau. Levels of these biomarkers did not correlate with underlying eye conditions, suggesting their specificity in association with cognitive change. This was perhaps the first study to correlate cognition with AD-related proteins in the vitreous humor. Results suggested that ocular proteins may have a role for early dementia detection in individuals at risk for AD.

"This is a great step in discovering the eye's potential role in diagnosing preclinical Alzheimer's disease, and further study is needed comparing protein biomarkers in the eye with more in-depth neurological testing," said senior author Dr. Manju Subramanian, associate professor of ophthalmology at Boston Medical Center.

The study was published in the March 8, 2019, online edition of the Journal of Alzheimer's Disease.

Related Links:
Boston Medical Center


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Electrolyte Analyzer
BKE-B
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.